Total Payments
$18,410
2024 Payments
$2,799
Companies
47
Transactions
803
Medicare Patients
6,571
Medicare Billing
$614,830
Payment Breakdown by Category
Food & Beverage$17,629 (95.8%)
Travel$729.43 (4.0%)
Education$32.17 (0.2%)
Other$19.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,629 | 797 | 95.8% |
| Travel and Lodging | $729.43 | 2 | 4.0% |
| Education | $32.17 | 3 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,158 | 147 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,626 | 71 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,275 | 108 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,234 | 56 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $832.78 | 25 | $0 (2024) |
| Grifols USA, LLC | $805.68 | 38 | $0 (2024) |
| Gilead Sciences, Inc. | $791.26 | 45 | $0 (2024) |
| Veran Medical Technologies, Inc. | $768.88 | 5 | $0 (2020) |
| Electromed, Inc. | $684.92 | 50 | $0 (2024) |
| Genentech USA, Inc. | $606.14 | 28 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,799 | 107 | AstraZeneca Pharmaceuticals LP ($568.86) |
| 2023 | $2,772 | 120 | AstraZeneca Pharmaceuticals LP ($778.71) |
| 2022 | $2,562 | 117 | Boehringer Ingelheim Pharmaceuticals, Inc. ($380.83) |
| 2021 | $2,121 | 105 | Boehringer Ingelheim Pharmaceuticals, Inc. ($378.03) |
| 2020 | $1,975 | 77 | Veran Medical Technologies, Inc. ($768.88) |
| 2019 | $2,187 | 91 | GlaxoSmithKline, LLC. ($761.81) |
| 2018 | $2,024 | 93 | GlaxoSmithKline, LLC. ($488.61) |
| 2017 | $1,970 | 93 | AstraZeneca Pharmaceuticals LP ($274.06) |
All Payment Transactions
803 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.79 | General |
| Category: HFCWO | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Immunology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $97.29 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $89.28 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.47 | General |
| Category: HFCWO | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.15 | General |
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.72 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Narcoplepsy | ||||||
| 10/10/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.79 | General |
| Category: HFCWO | ||||||
| 10/09/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Pulmonology | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $92.04 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,586 | 2,542 | $335,980 | $155,182 |
| 2022 | 19 | 1,755 | 2,783 | $347,765 | $168,028 |
| 2021 | 20 | 1,559 | 2,366 | $273,981 | $145,134 |
| 2020 | 22 | 1,671 | 2,526 | $292,415 | $146,485 |
Total Patients
6,571
Total Services
10,217
Medicare Billing
$614,830
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 283 | 446 | $57,980 | $38,292 | 66.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 127 | 638 | $79,750 | $38,208 | 47.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 155 | $27,125 | $13,460 | 49.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 76 | 76 | $17,100 | $11,250 | 65.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 153 | 164 | $15,580 | $9,433 | 60.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 65 | 69 | $22,425 | $9,062 | 40.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 42 | $21,000 | $6,788 | 32.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 216 | 306 | $15,300 | $5,526 | 36.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 188 | 226 | $19,210 | $5,343 | 27.8% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 42 | 42 | $14,280 | $3,634 | 25.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 37 | 38 | $12,920 | $3,478 | 26.9% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 25 | 27 | $11,475 | $2,651 | 23.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 50 | 53 | $3,180 | $2,059 | 64.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 44 | 45 | $2,700 | $1,720 | 63.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 58 | 58 | $5,510 | $1,604 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,340 | $1,395 | 59.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 59 | 66 | $660.00 | $554.40 | 84.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 30 | 33 | $805.00 | $251.13 | 31.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 14 | 14 | $5,880 | $220.87 | 3.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 17 | 17 | $340.00 | $144.80 | 42.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 14 | 14 | $420.00 | $107.97 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 319 | 529 | $67,920 | $46,457 | 68.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 124 | 584 | $70,225 | $31,617 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 209 | 227 | $21,165 | $13,588 | 64.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 52 | 168 | $28,275 | $13,066 | 46.2% |
About Dr. John Clark, MD
Dr. John Clark, MD is a Pulmonary Disease healthcare provider based in Spartanburg, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194798595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Clark, MD has received a total of $18,410 in payments from pharmaceutical and medical device companies, with $2,799 received in 2024. These payments were reported across 803 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($17,629).
As a Medicare-enrolled provider, Clark has provided services to 6,571 Medicare beneficiaries, totaling 10,217 services with total Medicare billing of $614,830. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine, Critical Care Medicine
- Location Spartanburg, SC
- Active Since 02/08/2006
- Last Updated 12/28/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194798595
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,581
- OFEV (Drug) $1,265
- DUPIXENT (Biological) $1,052
- Spin (Device) $754.73
- SMARTVEST (Device) $684.92
- NUCALA (Biological) $645.71
- Prolastin-C Liquid (Biological) $627.00
- TEZSPIRE (Biological) $545.63
- SYMBICORT (Drug) $485.44
- Arikayce (Drug) $482.29
- UPTRAVI (Drug) $481.76
- AIRSUPRA (Drug) $449.59
- OPSUMIT (Drug) $445.55
- FASENRA (Biological) $355.81
- STIOLTO RESPIMAT (Drug) $354.42
- BREZTRI (Drug) $337.76
- Sunosi (Drug) $322.54
- ANORO (Drug) $312.64
- OPSUMIT MACITENTAN (Drug) $306.29
- Xolair (Biological) $301.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Spartanburg
Joseph Boscia, Md, MD
Pulmonary Disease — Payments: $1.0M
Pulmonary Disease $1.0M
Charles Fogarty, Md, MD
Pulmonary Disease — Payments: $417,795
Pulmonary Disease $417,795
Dr. Farhan Siddiqui, M.d, M.D
Pulmonary Disease — Payments: $211,609
Pulmonary Disease $211,609
Supinder Channa, N.p, N.P
Pulmonary Disease — Payments: $8,200
Pulmonary Disease $8,200